Skip to main content
HLB PANAGENE Co., LTD. logo

HLB PANAGENE Co., LTD. — Investor Relations & Filings

Ticker · 046210 ISIN · KR7046210001 KO Professional, scientific and technical activities
Open in API
Filings indexed 267 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 046210

About HLB PANAGENE Co., LTD.

https://www.hlbpanagene.com/

HLB PANAGENE is a molecular diagnostics company specializing in proprietary Peptide Nucleic Acid (PNA) technology. The company develops, manufactures, and supplies a range of in vitro diagnostic (IVD) products for personalized medicine, with a focus on oncology and infectious diseases. Its portfolio includes diagnostic solutions for various cancers, such as lung, colorectal, and thyroid, by detecting key genetic mutations. The company also offers real-time PCR-based kits for infectious agents like HPV and STIs. Leveraging its PNA platform for high accuracy and rapid analysis, HLB PANAGENE provides PNA materials and diagnostic kits to a global market. Through its subsidiary, the company is expanding its capabilities into immunodiagnostics and point-of-care testing.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 96% confidence The document is titled “분기보고서 (제 51기) 2026년 01월 01일~2026년 03월 31일”, which translates to a Quarterly Report covering Q1 2026. It runs 184,659 characters, contains actual financial statements (summary and consolidated financials), notes, management analysis, auditor’s opinion, business overview, capital changes, and other substantive financial and operational detail. This fits the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
전환가액의조정
Capital/Financing Update Classification · 85% confidence The document is a formal disclosure of an adjustment to the conversion price of the company’s 5th series convertible bonds. It details pre- and post-adjustment conversion prices, share counts, adjustment basis and dates. This is not an earnings release, management report, or proxy statement, but a financing/capital structure update relating to convertible debt. Therefore it best fits the “Capital/Financing Update” category.
2026-04-20 Korean
전환가액의조정
Capital/Financing Update Classification · 78% confidence The document is a formal corporate disclosure announcing an adjustment to the conversion price of the company’s 6th tranche convertible bonds (CB). It details pre- and post-adjustment per-share conversion prices, reasons for the adjustment, calculation methods, effective dates, and links to related filings. This is not an annual or interim report, earnings release, board change notice, or dividend announcement. Instead, it concerns a financing instrument and reflects a capital structure change. According to our taxonomy, this falls under Capital/Financing Update (CAP).
2026-04-20 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document provides the full results of an Annual General Meeting (정기주주총회결과), including approval of financial statements, election/re-election of directors and auditors, and detailed voting percentages for each agenda item. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-25 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 91% confidence The document is a formal notice to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of outside directors (사외이사). It details dates of change, names, terms, and reasons for board member changes. This clearly falls under announcements of changes in the company’s board of directors, matching the Board/Management Information category.
2026-03-25 Korean
기업설명회(IR)개최
Investor Presentation Classification · 90% confidence The document is a short announcement of an upcoming corporate investor relations presentation (IR Day) with date, time, location, purpose, and logistics. It is not a financial report itself, nor an earnings release or regulatory notice of voting or dividends. The content clearly pertains to arranging an Investor Presentation event. Therefore, it fits the “Investor Presentation” category (Code: IP).
2026-03-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.